Trexquant Investment LP Amicus Therapeutics, Inc. Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

A detailed history of Trexquant Investment LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 479,222 shares of FOLD stock, worth $4.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
479,222
Holding current value
$4.6 Million
% of portfolio
0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$9.55 - $12.09 $4.58 Million - $5.79 Million
479,222 New
479,222 $5.12 Million
Q3 2023

Nov 13, 2023
BUY
$11.78 - $13.86 $706,517 - $831,267
59,976 New
59,976 $729,000
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $1.41 Million - $1.75 Million
129,447 Added 93.47%
267,931 $2.97 Million
Q4 2022

Feb 13, 2023
BUY
$9.89 - $12.7 $1.37 Million - $1.76 Million
138,484 New
138,484 $1.69 Million
Q2 2022

Aug 11, 2022
BUY
$6.23 - $11.12 $168,689 - $301,096
27,077 New
27,077 $291,000
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $115,699 - $146,568
-11,782 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$8.74 - $11.84 $162,939 - $220,733
-18,643 Reduced 61.28%
11,782 $113,000
Q2 2021

Aug 12, 2021
SELL
$8.71 - $10.72 $429,995 - $529,224
-49,368 Reduced 61.87%
30,425 $293,000
Q1 2021

May 13, 2021
BUY
$9.2 - $23.86 $231,849 - $601,295
25,201 Added 46.16%
79,793 $788,000
Q4 2020

Feb 11, 2021
BUY
$13.47 - $24.89 $458,087 - $846,459
34,008 Added 165.22%
54,592 $1.26 Million
Q3 2020

Nov 06, 2020
BUY
$12.89 - $15.89 $265,327 - $327,079
20,584 New
20,584 $291,000
Q2 2020

Aug 07, 2020
SELL
$8.86 - $15.69 $311,473 - $551,581
-35,155 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$6.63 - $11.16 $233,077 - $392,329
35,155 New
35,155 $325,000
Q4 2019

Feb 12, 2020
SELL
$7.48 - $10.75 $293,664 - $422,045
-39,260 Closed
0 $0
Q3 2019

Nov 08, 2019
SELL
$8.02 - $13.25 $242,324 - $400,348
-30,215 Reduced 43.49%
39,260 $315,000
Q2 2019

Aug 09, 2019
BUY
$10.96 - $14.4 $761,446 - $1 Million
69,475 New
69,475 $867,000
Q2 2018

Aug 07, 2018
SELL
$13.13 - $17.09 $296,357 - $385,738
-22,571 Closed
0 $0
Q1 2018

May 03, 2018
SELL
$13.76 - $17.12 $37,014 - $46,052
-2,690 Reduced 10.65%
22,571 $339,000
Q4 2017

Feb 09, 2018
BUY
$12.51 - $16.24 $63,813 - $82,840
5,101 Added 25.3%
25,261 $364,000
Q3 2017

Nov 09, 2017
BUY
$11.74 - $15.78 $236,678 - $318,124
20,160
20,160 $304,000

Others Institutions Holding FOLD

# of Institutions
313
Shares Held
312M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.69B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email